The big question after that was whether health plans would reimburse for it.
WellPoint Insurance, which has about 34 million members, has decided to pay for the screening. A spokesperson says the company determined that low dose spiral c-t screening is medically necessary to screen for lung cancer for individuals who have medical histories like those in the study.
So far, many other large insurers are still saying CT scanning is experimental and they won't pay.
